Search Results - Taniou, C

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis

    Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis by Bachert, Claus, Hellings, Peter W., Mullol, Joaquim, Hamilos, Daniel L., Gevaert, Philippe, Naclerio, Robert M., Joish, Vijay N., Chao, Jingdong, Mannent, Leda P., Amin, Nikhil, Abbe, Adeline, Taniou, Christine, Fan, Chunpeng, Pirozzi, Gianluca, Graham, Neil M. H., Mahajan, Puneet, Staudinger, Heribert, Khan, Asif

    Published in Allergy (Copenhagen)
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    PSS43 - DUPILUMAB IMPROVES ABSENTEEISM IN MODERATE-TO-SEVERE ATOPIC DERMATITIS PATIENTS COMPARED WITH PLACEBO IN PHASE 3 LIBERTY AD SOLO STUDIES

    PSS43 - DUPILUMAB IMPROVES ABSENTEEISM IN MODERATE-TO-SEVERE ATOPIC DERMATITIS PATIENTS COMPARED WITH PLACEBO IN PHASE 3 LIBERTY AD SOLO STUDIES by de Bruin-Weller, M., Eckert, L., Gadkari, A., Msihid, J., Taniou, C., Chen, Q., Ardeleanu, M., Rossi, A., Chen, Z., Bégo-Le Bagousse, G.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    D21 ASTHMA TREATMENT: GLUCOCORTICOIDS, BIOLOGICALS AND BEYOND:Dupilumab Improves Patient-Reported Outcomes In Uncontrolled Persistent Asthma: Results From A Phase 2b Clinical Trial

    D21 ASTHMA TREATMENT: GLUCOCORTICOIDS, BIOLOGICALS AND BEYOND:Dupilumab Improves Patient-Reported Outcomes In Uncontrolled Persistent Asthma: Results From A Phase 2b Clinical Trial by Chanez, P, Corren, J, Castro, M, Fabbri, L, Joish, V N, Evans, R E, H Graham, N M, Mastey, V, Abbe, A, Taniou, C, Mahajan, S, Teper, A, Pirozzi, G, Eckert, L

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: